Skip to main navigation Skip to search Skip to main content

A new measurement of residual cancer burden to predict survival after neoadjuvant chemotherapy.

  • W Symmans
  • , Florentia Peintinger
  • , C Hatzis
  • , H Kuerer
  • , V Valero
  • , B Hennessy
  • , M Green
  • , E Singletary
  • , G Hortobagyi
  • , L Pusztai

    Research output: Contribution to journal › Conference abstract

    Original languageEnglish
    JournalJournal of Clinical Oncology
    Publication statusPublished - 2006
    EventAnnual Meeting American Society of Clinical Oncology 2006 - Atlanta, United States
    Duration: 2 Jun 2006 → 6 Jun 2006

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Branches of science

    • 301 Medical-Theoretical Sciences, Pharmacy

    Cite this